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Abstract
This article serves to outline a research paradigm to investigate main effects and interactions of genes, environment, and development on behavior and
psychiatric illness. We provide a historical context for candidate gene studies and genome-wide association studies, including benefits, limitations,
and expected payoffs. Using substance use and abuse as our driving example, we then turn to the importance of etiological psychological theory in guiding
genetic, environmental, and developmental research, as well as the utility of refined phenotypic measures, such as endophenotypes, in the pursuit of
etiological understanding and focused tests of genetic and environmental associations. Phenotypic measurement has received considerable attention in the history
of psychology and is informed by psychometrics, whereas the environment remains relatively poorly measured and is often confounded with genetic effects (i.e.,
gene–environment correlation). Genetically informed designs, which are no longer limited to twin and adoption studies thanks to ever-cheaper genotyping, are
required to understand environmental influences. Finally, we outline the vast amount of individual difference in structural genomic variation, most of which
remains to be leveraged in genetic association tests. Although the genetic data can be massive and burdensome (tens of millions of variants per person), we argue
that improved understanding of genomic structure and functionwill provide investigatorswith new tools to test specific a priori hypotheses derived frometiological
psychological theory, much like current candidate gene research but with less confusion and more payoff than candidate gene research has to date.
Over the past 50 years, twin and adoption research has re-
vealed much about the origins of individual differences in be-
havior. We know that genetic factors influence individual dif-
ferences in a wide range of psychological outcomes, in part
because genetic factors appear to contribute substantially to
both the stability of behavior and behavioral change. We
also know that the genetic and environmental factors that
influence a specific behavioral outcome are not necessarily
statistically independent, yet we do not expect them to be ad-
ditive in their effect. The emergence of the concept of gene–
environment correlation (not to be confused with Gene 
Environment [GE] interaction) in the psychological litera-
ture arose out of a need to account for what might seem a
paradoxical result, at least initially: genetic factors appear to
contribute to differences in a wide array of environmental
measures, including peer-group characteristics, features of
the parent–child relationship, exposure to psychological
stress, and marriage and divorce (Kendler & Baker, 2007).
The paradox is resolved by recognizing that environments
are not distributed randomly: Individuals can have a major
impact in shaping their experiences both directly, through
the choices they make, and indirectly, through the reactions
their behaviors elicit from others (Jaffee & Price, 2007; Scarr
& McCartney, 1983). The concept that genetic and environ-
mental factors interact in their effects has been enthusiasti-
cally embraced by psychologists; GE interaction research
is one of the most rapidly expanding research paradigms
within psychology (Dick, 2011).
Today, the field of behavioral genetics is at a crossroads.
The twin and adoption studies that helped establish that
important psychological outcomes are influenced by genetic
factors in the aggregate are increasingly giving way to molec-
ular genetic investigations aimed at characterizing the nature
of the contribution of specific genetic variants. This transition
has not been entirely smooth. Reports of associations be-
tween specific genetic variants and behavior have been notor-
iously difficult to replicate, and the validity of research inves-
tigating the interaction between specific functional genetic
variants and the environment has recently been called into
question (Duncan & Keller, 2011; Risch et al., 2009). How
we think about the genetics of behavior is likely to be further
challenged by recent developments in genomic science,
which allow psychological researchers today to efficiently
and economically interrogate vast numbers of genetic var-
iants and will allow us in the not too distant future to sequence
the entire genomes of our research participants. Genetically
minded researchers will soon be awash with genetic data.
Now is the time to consider the implications of this new
type of genetic data and especially how it can be integrated
with our knowledge of the nature of environmental influence
to bring about a better understanding of individual differ-
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ences in, and developmental etiology of, behavior and mental
illness.
This paper is concerned with the impact of recent develop-
ments in genomics on the study of human behavior. It begins
by describing those developments. Because genomics has
been applied primarily to nonbehavioral phenotypes, a dis-
cussion of the challenges uniquely associated with behavioral
phenotypes follows. This includes a discussion of what we
have learned from twin and adoption research about how
best to assess the phenotype and conceptualize the nature of
environmental influence and, most critically, about how
genes, environment, and development can be integrated to
move psychology forward. Finally, we describe ongoing de-
velopments in genomics that are likely to soon have an impact
on behavioral research and speculate about what the nature of
what that impact is likely to be. Unfortunately, most of current
genomics research on human behavior is not developmentally
informed; we emphasize the importance of a developmental
perspective throughout.
Genome-Wide Association Study (GWAS): Genomics
in a Postgenomic World
The heritability estimates derived from twin and adoption stud-
ies imply that aggregate differences in the DNA sequences
we inherit contribute in some way to differences in our be-
havior. The conclusion of the Human Genome Project (for a
discussion, see Lander, 2011) has ushered in an era of pre-
cisely measured genomic variation. At the time of this writ-
ing, it is possible to obtain your entire sequence of DNA, ap-
proximately 3.5 billion base pairs, for a couple thousand
dollars. The genetic information currently used in candidate
gene studies by social and behavioral scientists is a mere frac-
tion of the total variation, and it represents only the tip of the
genomic iceberg. This section lays the foundation for our dis-
cussion of how to incorporate a developmental perspective
into modern behavioral genetic studies by briefly cataloging
common forms of genetic variation, describing how behav-
ioral scientists have typically investigated this variation, and
discussing how these behavioral investigations are likely to
change due to recent technological developments within
genomics.
Human DNA structure and variability
Normal human DNA is contained in 23 chromosomes: 22 au-
tosomes and 1 sex chromosome. Humans also have small
segments of DNA residing in cell mitochondria. We focus
here on chromosomal DNA. Each autosome has two copies:
one copy from the mother and one from the father. Each copy
is composed of base pairs of nucleotides, which are adenine
(A), thymine (T), cytosine (C), and guanine (G). The nucleo-
tides are always found in pairs, and the same nucleotides
always pair with each other. An example autosomal segment
along with major types of DNA variation can be found in
Figure 1.
Single nucleotide polymorphisms (SNPs) represent one
major source of genetic variation, with over 15 million
SNPs identified in humans as of this writing (Altshuler
et al., 2010). An example SNP is given in Figure 1, where
a single base pair differs between the maternal and paternal
autosomal segment. Of the 15 million cataloged SNPs, only
about 10 million are considered common in that they have a
minor allele frequency greater than 0.05 in one or more popu-
lations (the frequency in the population of the less frequently
occurring, or minor, allele). Note that the rarity and the defi-
nition of the minor allele is population specific. A particular
allele might be common in one population (e.g., individuals
of Han Chinese descent) and rare or even nonexistent in an-
other (e.g., individuals of Yoruban descent; see The Interna-
tional HapMap Consortium, 2003). Whatever racial popula-
tion is under study, it is the common SNPs, not the rare
SNPs, that have been the focus of most genetics research.
This is because, all else being equal, the larger the minor al-
lele frequency, the greater the power to detect an effect (Ban-
sal, Libiger, Torkamani, & Schork, 2010). Simply put, the
typical sample will not contain many individuals carrying
rare SNP alleles, so a focus on common SNPs is driven in
large part by pragmatics. There are many examples of studies
of SNPs within psychology. Perhaps most familiar among
these is the Val158Met (rs4680) polymorphism in catechol-
O-methyltransferase (COMT), which involves a single base
pair substitution that changes the coding sequence of the
gene (Meyer-Lindenberg et al., 2006).
SNPs have been the primary focus of behavioral genetics re-
search because they can be efficiently genotyped and have con-
sequently been extensivelymapped, but it is important to recog-
nize that other types of genetic variants are likely also to be
relevant to understanding behavior. Insertions/deletions (indels)
are variants where a small number of DNA bases (usually ,
100 bases) is either inserted into or deleted from the DNA se-
quence. The most prominent indel in psychology involves a
44-base deletion in the promoter region of the gene that codes
for the serotonin transporter (5-HTT; Heils et al., 1996). Vari-
able numbers of tandem repeats (VNTRs) represent another
form of genetic variation. VNTRs involve a short segment of
DNA that is repeated in tandem, but where the number of re-
peats varies from person to person. The most widely studied
VNTR in psychology involve a 48-base sequence in the coding
sequence of the dopamine receptor D4 gene that is repeated
from 2 to 10 times (Lichter et al., 1993). Finally, copy number
variants (CNVs) are relatively long sequences of DNA
(100,000 bases or more) where individuals can carry other
than the typical two copies. Although CNVs are generally
rare, they have been implicated in multiple diseases, including
autism and schizophrenia (Stankiewicz & Lupski, 2010).
Although it might seem that comprehensive assessment
of common SNP variations would require genotyping re-
search participants on each of the 10 million common
SNPs, a small fraction of this number would suffice. This
is because SNPs that are located near one another on the
same chromosome tend to be correlated with one another, a
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phenomenon known as linkage disequilibrium (LD). Chromo-
somes are not transmitted across generations unaltered. Rather,
during meiosis, when homologous chromosomes pair up, there
is an opportunity for an exchange, or recombination, of genetic
material between thematernally inherited and the paternally in-
herited chromosomes. The greater the distance between two
markers, the more likely it is that the markers will recombine.
Rather than occur randomly, however, recombination takes
place most frequently at recombination hotspots along the
chromosome. SNPs that are located within the same resulting
chromosomal block will consequently tend to be passed along
together to the next generation, and knowing one SNP in the
block allows one to infer the others with a high degree of
certainty. The upshot is that a minority of well-chosen SNPs
(e.g., 1 million) contain information about nearly all the com-
mon SNPs in the genome: thewell-chosen SNPs serve as prox-
ies for neighboring SNPs in high LD (Hirschhorn & Daly,
2005).
Until a few years ago, the existence of LD did little more
than allow geneticists to speculate about the possible im-
pact of comprehensively surveying common variation
throughout the entire genome (Risch & Merikangas,
1996). The advent of high-throughput SNP genotyping,
however, allowed speculation to become a reality. The first
GWAS was a proof of principle sponsored by the Wellcome
Trust and involved genotyping nearly 500,000 SNPs in
14,000 cases, representing seven different inherited disor-
ders and a common control sample of 3,000 (Burton
et al., 2007). This initial GWAS tentatively identified 24
SNPs as being associated with one of the seven disorders
and spurred hundreds of subsequent GWAS that have re-
sulted in the identification of several thousand SNP asso-
ciations (Visscher, Brown, McCarthy, & Yang, 2012).
Although this GWAS posed several methodological chal-
lenges, such as how to deal with the multiple-testing burden
(Hirschhorn & Daly, 2005) or how to control for subtle
population differences (such as ethnicity) between cases
and controls (Kang et al., 2010; Price et al., 2006), for
the most part these issues have been addressed and a
GWAS analysis today involves little more than a simple
Figure 1. Common forms of DNA variation. Humans have two chromosomes, one inherited from their father (paternal) and one from their
mother (maternal). Because the same bases always pair together in a single chromosomal strand (A with T; C with G), giving both pairs for
each strand is redundant, and DNA sequences are therefore represented by two rows of bases (“Simplified Representation” in the figure).
The CA single nucleotide polymorphism (SNP) represents the only difference between the maternal and paternal autosomal segments. Cataloged
in this figure is the SNP as well as several common types of structural variation, including insertion/deletions, block substitutions, inversions,
variable number tandem repeats, and copy number variants. Note that these particular variants are illustrative and that variation is not necessarily
within person. For example, this individual is heterozygous for the SNP, but other individuals may be homozygous CC or homozygous AA. The
same is true for structural variants. In the indel example, this individual has a GAT insertion on the paternal chromosome and no such insertion on
the maternal chromosome. Another individual may have GAT insertions on both chromosomes; yet another individual may lack the GAT inser-
tion altogether. [A color version of this figure can be viewed online at http://journals.cambridge.org/dpp]
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exercise of fitting an additive regression model, albeit re-
peated hundreds of thousands and even millions of times.
GWAS of anthropometric measures, medical diseases, and
behavioral traits
Although the statistical exercise is simple, reliable identifica-
tion of significant GWAS associations has been challenged
by two factors. First, addressing the multiple-testing burden
requires use of a statistical significance threshold of p , 5
1028 (Hirschhorn & Daly, 2005). Second, the effect associ-
ated with any specific SNP is very small, typically accounting
for less than 0.5% of the variance in the trait.
Addressing these challenges requires sample sizes that are
typically beyond the capabilities of any single investigator.
For example, to have 80% power to detect an effect account-
ing for 0.1% of variance using the GWAS p value threshold
would require a sample of nearly 40,000 individuals. Detec-
tion of these small effects has motivated the establishment of
large consortia, combining GWAS findings using meta-ana-
lytic methods. A consortium on height used data from over
180,000 individuals to identify 180 SNP variants that collec-
tively accounted for approximately 10% of the variance in
height (Allen et al., 2010). Consortia for body mass index
(BMI; nearly 250,000 individuals, 18 variants identified,
and 1.5% of variance accounted for; Speliotes et al., 2010)
and blood lipids (more than 100,000 individuals, 95 iden-
tified variants, 10%–12% of variance accounted for; Teslo-
vich et al., 2010) have produced similar results. Because
the percentage of phenotypic variance accounted for by
known SNPs is far less than heritability estimates from twin
and family studies, researchers have concluded that much
of trait heritability remains “missing” (Manolio et al., 2009).
The challenge associated with finding the missing heritabil-
ity is heightened in recognizing that the SNPs identified thus
far are likely the low-lying fruit, those with the largest effect
sizes. Accounting for greater percentages of variance will re-
quire ever-larger samples to identify even smaller SNP effects.
Figure 2 illustrates the projected sample sizes needed for height
and BMI to increase the variance being accounted for by iden-
tified SNPs. For height, to increase from the current 10% to
15% will require a combined sample of 487,000 individuals.
For BMI, going from the 1.5% that is accounted for now to a
mere 5% will require a projected sample size of 730,000.
Figure 2. Sample sizes and number of single nucleotide polymorphisms (SNPs) required to explain significant proportions of variance in an-
thropometric traits. These data are based on visual inspection of graphs provided in Allen et al. (2010) and Speliotes et al. (2010); see the original
sources for full details. Note the wide difference in trend for height (estimates based on sample of 185,000 subjects) and for body mass index
(BMI; estimates based on sample of235,000 subjects). Height is much more promising, in that it will take500,000 samples to obtain enough
genome-wide significant SNPs to account for 15% of the variance in height. In contrast, for BMI it is projected that 700,000 samples are re-
quired to account for only 5% of the variance in height. The cause of the discrepancy in genetic architecture of these traits is unknown. These
values differ slightly from what is described in the text because extrapolating beyond currently available sample sizes required sample splitting
and replication procedures in the original studies for an unbiased estimate of effect sizes. [A color version of this figure can be viewed online at
http://journals.cambridge.org/dpp]
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As with anthropometric traits, large samples have been
needed to reliably identify SNP effects in GWAS of behavioral
and psychiatric traits. Ameta-analysis (deMoor et al., 2009) of
17,375 individuals assessed for Big 5 personality traits re-
turned one genome-wide significant SNP for openness, and
one for conscientiousness, neither of which were subsequently
replicated in a small sample (N ¼ 3,294). A genome-wide
meta-analysis of alcohol consumption (Schumann et al.,
2011) returned one SNP identified in a discovery sample of
26,316 individuals and replicated in a sample of 21,185, and
a recent GWAS investigation of more than 12,000 individuals
with bipolar disorder and 50,000 controls reported 18 repli-
cated SNP effects (Sklar et al., 2011). Unfortunately, most of the
heritable variance for behavioral phenotypes remains missing.
For example, a GWAS analysis of more than 3,000 individuals
with schizophrenia and more than 3,000 controls was able to
account for approximately 3% of the variance in schizophrenia
liability (Purcell et al., 2009), far less than the estimated 80%
liability heritability for schizophrenia.
However, accounting for missing heritability may not be a
simple matter of achieving ever-larger pooled sample sizes if
the relevant genetic variation is not being captured by the
GWAS platforms being used. Genome-wide complex trait
analysis (GCTA; Yang, Lee, Goddard, & Visscher, 2011;
Yang, Manolio, et al., 2011), is a statistical method that uses
the genetic relatedness among individuals, as measured by
the genotyped SNPs, to estimate the variance in the pheno-
type accounted for by the aggregate of all those SNPs. The
method can be likened to a twin study, except that instead
of using twin zygosity to estimate genetic relatedness,
GCTA uses the aggregate genetic similarity, as estimated
by the genotyped SNPs, among each pair of research partic-
ipants in a sample. Consequently, although GCTA does not
tell us which of the million or so genotyped SNPs contribute
to phenotypic variance, it does tell us how much variance the
relevant SNPs would account for if we could sift them out. In
a sample of only about 4,000 individuals, Yang et al. (2010)
found that the genotyped common SNPs accounted for 45%
of the variance in height, a great deal more than the 10.5% of
variance found by the Allen et al. (2010) meta-analysis of ap-
proximately 185,000 individuals, but still a far cry from the
80% heritability routinely identified in twin studies. GCTA
has been similarly used in large samples to estimate the var-
iance accounted for by genotyped common SNPs to be 23%
for schizophrenia (Lee et al., 2012) and 40%–50% for general
cognitive ability (Davies et al., 2011), values both well below
heritability estimates for these phenotypes derived from twin
and family data. Consequently, although much of the herita-
bility of complex phenotypes could, in principle, be
accounted for by the SNPs genotyped in GWAS, clearly a
large portion of the heritability would remain missing even
if we could achieve pooled samples in the multiple millions.
In all likelihood there are sources of genetic variance in addi-
tion to common SNPs, and the additive regression model that
has been the basis of GWAS analysis may need to be ex-
tended to consider nonadditive effects.
Although GWAS has been successful in identifying a
large number of SNP variants for a large number of important
traits, some researchers have expressed disappointment that
SNP effects have been uniformly small and that the vast ma-
jority of heritable variance remains missing (Gershon, Alliey-
Rodriguez, & Liu, 2011). Nonetheless, GWAS has moved the
field beyond a research agenda being driven by a few false-
positive genetic findings (Ioannidis, Castaldi, & Evangelou,
2010). We believe the question now is not so much whether
GWAS has worked as it is how we can use what we have
learned about the genetic architecture of complex phenotypes
to better understand the origins of individual differences in
behavior. We are optimistic about the future of genetically in-
formed behavioral research, especially if that research builds
on what we have learned about the nature of heritable varia-
tion for behavioral traits, involves a consideration of environ-
mental and developmental context, and expands to consider
sources of genetic variance other than the common SNPs
that have been the focus of GWAS.
The Nature of the Behavioral Phenotype
Phenotypic definition and measurement
Despite a long history in psychology of measurement and as-
sessment, much work on the genetics of psychiatric disease
has focused on diagnostic status or symptomatology of men-
tal disorder categories defined by the Diagnostic and Statisti-
cal Manual of Mental Disorders (DSM; American Psychiat-
ric Association, 2000). In part, this is a practical issue:
DSM diagnoses and symptoms are often gathered as part of
standard assessment protocol. This makes DSM-related mea-
surements useful because they can easily be combined across
studies in meta-analytic style, which has become standard
practice in genetics.
Although a categorical measurement of disease status may
effectively facilitate the pooling of resources, it may not be an
optimal way to measure disease and/or a trait. It is well known
that binary diagnoses throw away an immense amount of in-
formation, and have lower statistical power compared even to
rough quasicontinuous measures of the same constructs, like
symptom counts (Markon, Chmielewski, & Miller, 2011). It
is rarely true in psychology that a binary classification is bet-
ter for statistical analysis than a quasicontinuous one (Grove,
1991), but arguments favoring the use of quantitative indica-
tors is not based on statistical power alone. Some of the phe-
notypic measurements of interest to psychopathologists ap-
pear to be better represented by continuous dimensions of
variation rather than as discrete entities (Krueger, Markon,
Patrick, & Iacono, 2005; Vrieze, Perlman, Krueger, &
Iacono, 2011; although see Grove &Vrieze, 2010; and Vrieze,
2012), a conclusion that has moreover been consistently
supported in behavioral genetic research.
Used well, measurement models inform the nature and
etiological structure of a phenotype for behavioral genetic
investigations. For example, alcohol, nicotine, and cannabis
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dependence have long been considered as technically sepa-
rate conditions in the DSM, but work during the last decade
indicates that a significant proportion of etiology among
them is shared and is largely genetic in origin (Kendler, Ja-
cobson, Prescott, & Neale, 2003). Factor analytic approaches
give single-factor solutions, suggesting similar shared causal
mechanisms among nicotine, alcohol, marijuana, and illicit
drugs (Hicks, Schalet, Malone, Iacono, & McGue, 2011;
Krueger et al., 2002), which begs the question of what these
shared causes might be. One popular answer involves the
gateway hypothesis (Kandel & Jessor, 2002), where it is pro-
posed that the use of one drug causes use of another. Perhaps
individuals use multiple drugs in their search for bigger and
better highs, resulting in the strong correlations that are ob-
served among substance dependence symptoms. Another hy-
pothesis is that more impulsive, sensation-seeking indi-
viduals are more likely to experiment indiscriminately with
drugs, and will use and become addicted to multiple drugs
simultaneously, which would also result in observed correla-
tions among different drugs. This has been termed the disin-
hibitory hypothesis, holding that the more disinhibited one is,
the more likely one is to experiment and use indiscriminately
(Iacono, Malone, & McGue, 2008).
Like many etiological theories, the gateway and disinhibi-
tory hypotheses are developmental, in that they hypothesize
the existence of etiological processes that progress, over
time, to pathological behaviors such as drug abuse or addic-
tion. Rigorous testing of these hypotheses requires develop-
mentally informed sampling and measurement, likely not
new ideas to readers of this journal. More novel, perhaps, is
the utility of genetically informative designs, even in cases
where one is not explicitly interested in the role of genetic fac-
tors. For example, Irons, McGue, Iacono, & Oetting, (2007)
used a genetic design called Mendelian randomization
(MR; Smith, 2011) to test key predictions of the gateway
model. Nearly 50% of individuals of East Asian ancestry
inherit a variant in the aldehyde dehydrogenase 2 (ALDH2)
gene that diminishes their ability to metabolize alcohol (Luc-
zak, Glatt, &Wall, 2006). Those who inherit the gene variant
are likely to experience various signs of dysphoria following
ingestion of even a small amount of alcohol and consequently
curb their drinking. Inheriting the ALDH2 variant is essen-
tially random, at least among East Asians, and thus provides
a natural analog to experimental randomization. The question
of relevance here is whether individuals who inherit the
ALDH2 variant show, in addition to reduced drinking, dimin-
ished rates of the behaviors the gateway model posits to be a
consequence of use of gateway substances such as alcohol.
Irons et al. (2007) found no evidence in support of the gateway
model in that rates of nonalcohol substance use and disinhib-
ited behavior did not vary as a function of ALDH2 status
among individuals of East Asian ancestry. Nonetheless, one
limitation of the (Irons et al., 2007) study is especially rele-
vant in the current context: Participants were still in late ado-
lescence (average age of 18.3 years), and gateway effects may
not emerge until later in development. That is, there may be a
GeneDevelopment (GD) interaction between ALDH2
and nonalcohol substance use. Continued follow-up of the
sample is warranted.
Other research using a variety of designs, summarized by
Iacono et al. (2008), has taken a more explicitly develop-
mental perspective to establish that a broad risk for abusing
multiple drugs is disinhibitory, at least in adolescence. Rela-
tive to adults, adolescents are more disinhibited (Steinberg,
2007), and one expects correlations among alcohol, nicotine,
and marijuana dependence to be highest at younger ages,
when individuals’ behavior is more driven by impulsivity
and sensation seeking, and then decline over time as the
youths age and become more responsible. Vrieze, Hicks,
McGue, and Iacono (in press) used a large prospective longi-
tudinal study of twins with measures of substance depen-
dence taken at ages 11, 14, 17, 20, 24, and 29. Although over-
all rates increased until ages 20–24 and declined thereafter,
the correlations among alcohol, nicotine, and marijuana
dependence strictly declined from adolescence into young
adulthood. In addition, by using the twins we noted GD in-
teraction. At younger ages, the correlations among nicotine,
alcohol, andmarijuanawere due largely to genetic influences.
At older ages, the correlations were more strongly due to non-
shared environment. That is, as the individuals aged, their in-
dividual life experiences increasingly influenced their pro-
pensity to use multiple drugs simultaneously.
Clearly, the same measure of a phenotype, such as symp-
tom counts of alcohol dependence, can be the product of dras-
tically different etiology depending on developmental stage
and environmental considerations that exist when the mea-
surement is taken. This can pose serious problems for genetic
studies in samples where the genetic etiology of a phenotype
is heterogeneous. An excellent example comes from recent
research on obesity in which Lasky-Su et al. (2008) found a
SNP in the roundabout homolog 1 gene was significantly as-
sociated with obesity in pediatric samples but only margin-
ally significant in adult samples, a G  D interaction. In
work on skin cancer, Duffy et al. (2010) identified a SNP
in the interferon regulatory factor 4 gene where the T allele
was associated with high freckling in adolescents and adults
but was only associated with high nevus counts in adoles-
cents. (High nevus counts increase risk of melanoma.) The
authors suggest this is likely a GE interaction: adolescents
in this cross-sectional sample sunbathed more frequently and
for longer periods than the adults had. The adults and the ado-
lescents had the risk gene, but sun exposure is required to po-
tentiate its effects.
Obvious analogues exist for substance use phenotypes.
There are a host of genes that theoretically impact upon pro-
pensity for addiction but are irrelevant unless one is exposed
to the substance. This appears to be true for the nicotinic
receptor, neuronal acetylcholine receptor subunit a-3
(CHRNA3), which was very strongly associated with number
of cigarettes smoked per day in a sample of 74,000 current
smokers ( p , 2.8  10273) but was not associated with
smoking initiation in a combined sample of approximately
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74,000 smokers and approximately 70,000 nonsmokers (Fur-
berg et al., 2010). The effect of CHRNA3 is lost on those who
have never smoked. Alcohol metabolism and ALDH2, the
gene discussed above responsible for flushing in many indi-
viduals of East Asian descent, also is likely not protective for
alcoholism until someone starts drinking and thereby feels the
effect of that genotype.
The hypothesized existence of heterogeneity in genetic
etiology, that different genes are relevant under different
environmental or developmental circumstances, is in tension
with the most popular current approach to evaluating com-
mon variants: combining as many samples as possible
through meta-analysis. In the presence of between-sample
heterogeneity of genetic associations, meta-analysis can fail
(DerSimonian & Kacker, 2007; Han & Eskin, 2012; Tang,
2006), at least for those SNPs that are sample specific (e.g.,
due to developmental differences between some of the sam-
ples in the study). Although this certainly is a problem, it is
currently prohibitively difficult to amass phenotypically, de-
velopmentally, and environmentally homogenous samples
powerful enough to identify common SNP interaction effects.
Meta-analysis is not perfect, but if used well it can identify at
least those SNPs that transcend whatever heterogeneity exists.
New methods are being developed that determine which indi-
vidual studies in the meta-analysis contain the SNP effect,
which likely do not, and which studies are ambiguous (Han
& Eskin, 2012). Such tests can provide insight into the source
of genetic heterogeneity to guide future efforts. The existence
of etiological heterogeneity between diverse samples is
important to consider but should not impede efforts at consor-
tia building and GWAS meta-analysis.
Other genotypes, such as those associated with behavioral
disinhibition or impulsivity, are theoretically relevant for
both initiation and maintenance of use (Zucker, Heitzeg, &
Nigg, 2011). Measurements of these traits may show hetero-
typic continuity (Costello, Mustillo, Erkanli, Keeler, & An-
gold, 2003), in that the same etiological process manifests dif-
ferently at different stages of development and/or in different
environments. For example, problem behavior before age 15,
such as tobacco use, alcohol use, trouble with police, and
early sexual intercourse, are predictive of psychiatric disor-
ders at age 20, such as nicotine dependence, alcohol depen-
dence, drug dependence, and antisocial personality disorder
(McGue & Iacono, 2005). Studies of familial transmission
also suggest a role of heterotypic continuity. Parental sub-
stance use or antisocial diagnosis is associated with increased
risk for child conduct disorder, attention-deficit/hyperactivity
disorder, and oppositional defiant disorder (Bornovalova,
Hicks, Iacono, & McGue, 2010). These studies suggest that
part of the genetic predisposition to early childhood problem
behavior and disorder is also relevant for adult disorders, even
though the phenotypic measures can be quite different.
One can begin to see the importance of phenotypic mea-
surement and developmental etiological theory in under-
standing a phenotype. Some aspects of the etiology and mea-
surement structure of substance use phenotypes change from
adolescence to young adulthood (Vrieze et al., in press) and
other aspects appear reliable over time (Bornovalova et al.,
2010; McGue & Iacono, 2005). Genes found to be associated
with substance use, at whatever age, will require develop-
mental elaboration of this kind in order to inform etiology, in-
tervention, and measurement. The overriding goal of behav-
ioral genetics is not to engage in statistical self-indulgence
to explain variance in our pet phenotypes but rather to test
etiological developmental theories of behavior. With the
ever-increasing availability of measured human genomes,
we expect an exciting scientific future: genetic findings will
force us to discard, amend, and refine theories, leading to im-
proved empirical measures of phenotypes and environments
designed to test the refined theory, resulting in ever more ge-
netic, biological, and environmental findings.
We expect a product of this cycle to be a pursuit of pheno-
typic and endophenotypic refinement. A problem facing
those exploring the genetic underpinnings ofDSM categories,
or most other standard clinical or questionnaire measures, is
that whatever utility they have in guiding research and treat-
ment, they are not grounded in biology. This leaves open the
question of how useful they can be as target phenotypes in ge-
netic association studies. As discussed, one explanation for the
problems encountered identifying replicable genetic associa-
tions with psychiatric disorders lies in the possibility that the
disorders are too etiologically heterogeneous and complex to
facilitate gene finding. An additional complication is that these
behavioral phenotypes are far removed from the action of genes
at the level of the brain. These brain processes interact with the
environmental context to influence various observed patholog-
ical behaviors, some constellation of which defines aDSM dis-
order or trait measurement thereof. An endophenotype ap-
proach that targets more directly the genetic architecture of
the underlying brain processes may provide a useful comple-
ment to investigations focused on DSM categories, symptom
counts, and related trait dimensions.
An endophenotype is a heritable, biologically based, ob-
jectively quantifiable measure that is associated with a psy-
chiatric phenotype because both share a common genetic in-
fluence. Endophenotypes hold promise for gene finding
because they are believed to (a) be more proximal to the ef-
fects of genes; (b) tap one of many facets of a disorder and
thus be more etiologically homogeneous than the associated
disorder; (c) be more highly heritable than the disorder,
thus likely to produce larger effect sizes and boost GWAS
power; or, (d) because the endophenotype deals with an etio-
logically homogenous facet of the disorder, be associated
with fewer genes each of which may be expected to have
larger individual effect sizes. To the extent that an endophe-
notype taps a biological mechanism associated with the de-
velopment of a disorder, identifying its genetic underpin-
nings could provide clues regarding how the relevant gene
or genes affect brain processes that underpin a disorder. It
is unlikely that there are many DSM disorders with a specific
neurological etiology and likely that there are different disor-
ders that share underlying neural processes. To the extent that
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a brain process (e.g., dysfunctional presynaptic prefrontal
cortex) heightens risk for the development of more than
one disorder (e.g., substance dependence and mood disor-
ders; Goto, Yang, & Otani, 2010), an endophenotype has
the potential to provide leads to genes that affect disparate dis-
orders as well as genes that help explain why certain disorder
comorbidity combinations occur. Animal models derived
from endophenotypes may be potentially useful for identify-
ing genes, their role in neurodevelopment, and their effects on
brain circuitry (Kaffman & Krystal, 2012). Many papers have
been written regarding the ideal properties of an endopheno-
type, with a recent review paper by Iacono andMalone (2011)
detailing these characteristics from a developmentally in-
formed perspective.
Endophenotypes are by their nature developmental. Their
utility for gene finding derives in part from their ability to
identify genetic risk in the absence of manifest psychopathol-
ogy, and a valid endophenotype should predict the subse-
quent development of a disorder in individuals and their
first-degree relatives. The ideal endophenotypewould change
little with development after a certain age or change in a pre-
dictable manner. In addition, it should be relatively stable
over time and affected little by changes in state, including
changes associated with acute illness and remission of disor-
der. In their review, Iacono and Malone (2011) showed how
reduced amplitude of the P300 event-related potential ob-
tained from an oddball task (e.g., Begleiter, Porjesz, Bihari,
& Kissin, 1984) shows promise as a developmental endophe-
notype indexing genetic risk for substance abuse and related
disorders. This endophenotype is present in the preadolescent
offspring of alcoholic fathers, is evident early in life for those
who go on to develop substance use disorders, changes with
development in predictable fashion (with the developmental
trajectory of change itself being genetically influenced), is
stable over several year intervals, and is associated with sub-
stance use disorders because of likely shared genetic influ-
ences. Molecular genetic investigations of P300 amplitude,
including GWAS, are now under way.
Despite the promise of endophenotypes, skepticism has
surfaced regarding the possibly idealized assumptions on
which they are based and the likelihood that they will facili-
tate gene finding (Flint & Munafo, 2007). However, it seems
clear that the endophenotype strategy has yet to be fully
exploited. Multivariate methods targeting the molecular ge-
netic basis of the covariance between the endophenotype
and its associated disorder have yet to be fully tested, and
using endophenotypes in combination may prove fruitful. Ia-
cono, Carlson, and Malone (2000) showed that using two en-
dophenotypes in combination was associated with greatly in-
creased risk for developing substance use disorders when
compared to either endophenotype alone; that is, the endo-
phenotypes each added incrementally to the prediction of
who would develop a substance use disorder. Greenwood,
Light, Swerdlow, Radant, and Braff (2012), obtained promis-
ing multivariate results using a novel bootstrapping approach
designed to counter problems associated with multiple test-
ing. In Greenwood et al. (2011), they simultaneously exam-
ined the association among 12 heritable schizophrenia endo-
phenotypes and 1,536 SNPs, covering 94 biologically
relevant genes. They found evidence supporting the involve-
ment of 46 genes, including those involved in neurodevelop-
ment, and reported that 8 genes affected 4 or more endophe-
notypes, suggesting pleiotropy. These studies and others
(Iacono, McGue, &Krueger, 2006; Luck et al., 2011) demon-
strate that it is currently feasible to obtain endophenotype
measures on samples numbering in the thousands. Although
these Ns are not large by current GWAS standards, with im-
proved statistical methods, pooling across sites, and reliance
on putative endophenotypes that show strong construct valid-
ity, there is ample reason to be optimistic about the payoff
from an optimally applied endophenotype study. Finally,
even if endophenotypes do not help in gene identification,
once disorder/trait-relevant genes are found, the association
of these genes with endophenotypes may help identify rele-
vant brain mechanisms (de Geus, 2010). This, in turn, would
not only assist our understanding of the neurobiological ef-
fects of specific genetic polymorphisms but also enrich our
theoretical understanding of the etiological mechanisms con-
tributing to the development of psychopathology.
Measuring, selecting, and aggregating environments
To disentangle genetic and environmental influences on be-
havior and disease, behavioral geneticists have traditionally
used twins or adoptees and their families, which are well
suited to this task. In one test of the disinhibitory hypothesis
of substance dependence, Keyes, Legrand, Iacono, andMcGue
(2008) used an adoption design to evaluate the environmental
impact of parental smoking on child tobacco, alcohol, and drug
use. In biological children, parental smoking was associated
with increased risk for use of all drugs. In adoptive children,
it was only associated with a mild increase in smoking and
had no association with alcohol or other drug use. A typical
family study (of biological parents and children) would have
concluded that parental smoking is a risk factor for drug use,
without elaboration. Having a genetically informative design,
however, elucidated the etiology. That is, parental smoking
conveys risk both through an environmentally mediated path-
way that appears to be specific to offspring smoking and
through a genetically mediated pathway that is general to off-
spring substance use.
Measuring and defining environments has received much
less attention in clinical psychology and psychiatry than phe-
notypic measurement. This trend is changing, and current ef-
forts such as the PhenX Toolkit (Hamilton et al., 2011) de-
vote entire measurement domains to psychosocial history
and social environment, providing a total of 30 assessment
protocols, ranging from child maltreatment to job strain.
The toolkit is a multidisciplinary effort to standardize assess-
ment for the genetic study of complex disease.
Studies of GE interaction often select candidate environ-
ments on the basis of a priori hypotheses. This is more than
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reasonable when there exists strong a priori evidence that
some environment is likely to affect the phenotype differently
depending on genotype. However, measures of the environ-
ment often correlate, sometimes strongly. A standard mea-
surement approach would model those correlations under
the usual assumption that different environmental measures
are imperfect measures of the same construct (Cronbach &
Meehl, 1955), but this is infrequently explicitly done. For ex-
ample, in the evaluation of GE effects of externalizing be-
haviors, Hicks, South, DiRago, Iacono, and McGue (2009)
report an average correlation of .31 among adolescent envi-
ronmental adversity measures, indicating etiological overlap
and the potential utility of combining environments through
a factor analytic measurement model.
Evaluating defensible aggregate measures of environ-
mental risk might be a preferable starting point for GE stud-
ies. Although such a procedure ignores the possibility of
interactions at finer levels of environmental detail, the multi-
ple-testing burden of possible environmental measures times
possible SNPs becomes too high too quickly for available
sample sizes. Perhaps more to the point, this approach to mea-
suring the environment directly acknowledges that environ-
mental risk exposures seldom occur in isolation. For example,
adolescents who use substances tend to have problematic re-
lationships with their parents, to have difficulty performing at
school, and to socialize with deviant peers. Rather than focus-
ing on specific environmental risk factors, aggregating envi-
ronmental measures emphasizes the accumulation of risk
across domains in the etiology of problem behavior. Work
from our group has demonstrated that individual risk factors
can be profitably combined into broader omnibus indicators,
providing valuable summaries of environmental risk (John-
son, McGue, & Iacono, 2006; Keyes, Iacono, & McGue,
2007; Legrand, McGue, & Iacono, 1999).
Gene–environment correlational processes, whereby mea-
sures of environmental risk come to be heritable, complicate
interpretations of associations of the environment with out-
come (Scarr & McCartney, 1983). For example, peer-group
characteristics are substantially correlated with adolescent
substance use (Hicks et al., 2009). Rather than being simply
causal, these associations may reflect that the underlying ge-
netic liability for disinhibition can manifest in both choice of
peers and decision to experiment with substances (Harden,
Hill, Turkheimer, & Emery, 2008). A recent meta-analysis
documented that gene–environment correlation is pervasive,
with the average heritability of measures of psychosocial risk
being 27% (Kendler & Baker, 2007). Nonetheless, it is
important to recognize that genetically influenced factors
can still exert environmentally mediated effects on outcome
(O’Connor, Deater-Deckard, Fulker, Rutter, & Plomin,
1998; Rutter, Pickles, Murray, & Eaves, 2001). That is, expo-
sure to deviant peers may be amanifestation of a heritable dis-
position and result in increased substance misuse through the
mechanisms of peer facilitation and encouragement.
A second process that is also fundamental to understand-
ing the joint influence of genetic and environmental factors
is gene–environment interaction (Thapar, Harold, Rice,
Langley, & O’Donovan, 2007). Rather than being uniform
across individuals, genetic influences are in many cases likely
to depend on environmental context. For example, there is a
growing research literature indicating that genetic influences
on cognitive ability are diminished in environments that do
not provide adequate opportunity for intellectual stimulation
(Taylor, Roehrig, Hensler, Connor, & Schatschneider, 2010;
Turkheimer, Haley, Waldron, D’Onofrio, & Gottesman,
2003). Other research has shown that genetic influences on
adolescent misbehavior are amplified in the presence of
peer deviance, substance availability, and adverse family
environments (Agrawal et al., 2010; Button, Lau, Maughan,
& Eley, 2008; Feinberg, Button, Neiderhiser, Reiss, & Heth-
erington, 2007; O’Connor, Caspi, Defries, & Plomin, 2003)
and diminished in positive contexts, such as being academi-
cally or prosocially engaged (Hicks et al., 2009; Johnson
et al., 2010).
Characterizing the nature of environmental influence
The goal of GE research is, of course, to determine whether
and how environmental factors modulate genetic influences.
However, the existence of G–E correlation raises the possibil-
ity that what may look like GE may actually be GG (Jaf-
fee & Price, 2007). Advancing GE research will require not
only better phenotypic or endophenotypic measurement and
identification of the relevant genetic variants but also proper
characterization of environmental effects. Behavioral genetic
methodology has a major role to play in this effort (Rutter,
2007). We have already provided two examples where behav-
ior genetic methodology was instrumental in resolving an
ambiguous association between a putative environmental
risk factor and a behavioral outcome. In the first, the MR
method was used to determine that adolescent alcohol use
may not be a gateway to other substance abuse in adolescence
(Irons et al., 2007). However, MR depends on the existence of
well-characterized causal genetic variants that mimic envi-
ronmental exposure (Smith & Ebrahim, 2003). Given the
yield to date from large-scale GWAS, it is reasonable to ex-
pect that MR will see limited application in psychology, at
least in the near term. Nonetheless, it could be used more
than it is now. For example, there are enough obesity-related
genetic variants identified forMR to be used to effectively ex-
plore the psychological consequences of obesity (Timpson
et al., 2009).
Our second example involved the use of an adoptive-fam-
ily design to determine that the environmental consequences
of parental smoking were specific to adolescent smoking.
Adoption studies are one of the most powerful methods for
identifying familial environmental influences, although they
have been rarely utilized within developmental psychology.
This is perhaps, in part, a consequence of the logistical chal-
lenges associated with undertaking an adoption study. It is
also likely a result of the belief that fundamental differences
between adoptive and nonadoptive families severely limit
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the generalizability of adoption research (Rutter et al., 2001).
Although there are certainly differences between adoptive
and nonadoptive families, in general these differences are
small (Rueter, Keyes, Iacono, & McGue, 2009) and when
they are not can be accounted for by proper research design
(McGue et al., 2007). Adoption studies, as well as variants
based on assisted reproductive technologies, are underuti-
lized within psychology.
A co-twin control study represents a third behavioral ge-
netic design for characterizing the nature of environmental in-
fluence. Unlike the previous two, the co-twin control design
is widely used, at least by behavioral geneticists. The logic of
the design derives from the counterfactual model of causality
(McGue, Osler, & Christensen, 2010). Briefly, monozygotic
(MZ) twins who are discordant on exposure to some putative
environmental agent represent an approximation to the ideal
counterfactual design that is arguably second only to that of
a randomized experiment. This is because MZ twins share a
genotype and a rearing environment. Thus, for example, if
early age of alcohol initiation is a risk factor for alcoholism
in adulthood, then within MZ twin pairs discordant for early
alcohol use, we should observe greater alcoholism risk
among the twins who are early users than those who are not
(McGue, Iacono, Legrand, & Elkins, 2001; Prescott & Kend-
ler, 1999).
An early application of the co-twin control design in-
volved female twins discordant for childhood sexual abuse.
Within discordant pairs, the abused twin was significantly
more likely to develop an alcohol use disorder than the non-
abused twin (Kendler et al., 2000), indicating that the associa-
tion between childhood sexual abuse and adult alcohol use
disorder could not be attributed to confounding with family
environment or genetic factors. Subsequently, the co-twin
control design has been used to explore a broad range of pu-
tative environmental agents, including, for example, the im-
pact of early cannabis abuse on drug use escalation (Grant
et al., 2010; Lynskey et al., 2003), the impact of college atten-
dance on drinking (Slutske et al., 2004), and early adolescent
sexual behavior on risky adult sexual behavior (Huibregtse,
Bornovalova, Hicks, McGue, & Iacono, 2011).
Testing for Genetic Interactions at the Level
of the Genome
GE interactions in association studies have been even more
difficult to identify than main effects, despite early promising
leads (Duncan & Keller, 2011). The classic example of GE
in psychology involves the serotonin transporter linked poly-
morphic region (5-HTTLPR) in the promoter region of the se-
rotonin transporter gene SLC6A4. 5-HTTLPR was found in a
seminal GE study to interact with a measure of stressful life
events to predict adult depression (Caspi et al., 2003). This re-
sult is perhaps the most well-studied and well-characterized
interaction in psychiatric genetics. Yet, a decade since the
2003 study, the existence and extent of the interaction remains
unclear, with disagreement among experts as well as dueling
meta-analyses provided in support of very different conclu-
sions (Caspi, Hariri, Holmes, Uher, & Moffitt, 2010; Karg,
Burmeister, Shedden, & Sen, 2011; Risch et al., 2009). Re-
gardless of whether this interaction is real, the limitations of
existing GE research to clearly resolve the issue should mo-
tivate psychologists to critically evaluate existing G  E
methodology.
The Caspi et al. (2003) GE model has provided a pop-
ular blueprint followed by investigators worldwide in testing
for GE effects. The approach is to select environments and
candidate genes, which are usually measured by a handful of
common SNPs, based on a priori hypotheses about functional
importance. It has been called for this reason a candidate G
E (cGE) approach. Although theory-guided approaches are
undoubtedly reasonable in some cases, they have yet to de-
liver in behavior genetics research. Much has been learned
about genomic function since the Caspi study was published,
including our knowledge (from GWAS) of the vanishingly
small main effects for individual SNPs. It takes considerably
more power to detect interaction effects compared to main ef-
fects (e.g., a common rule of thumb is four times as many sub-
jects; Thomas, 2010a), owing in large part to the multiplicity of
alternative hypotheses tested. Most candidate gene studies, in-
cluding the original Caspi study, are undertaken on very small
samples (the majority with N , 500), such that the power to
detect an effect is miniscule and Type I errors are common
(Duncan & Keller, 2011). To place this in context, the average
SNP known to be associated with height accounts for 0.06% of
the variance.Under reasonable assumptions, to have80%power
to detect a GE interaction of similar magnitude at an alpha of
0.05 would require more than 10,000 unrelated participants.
From a genome-wide perspective, 80% power to detect the
same effect at p , 51028 would require a sample size of
approximately 53,000 participants. Clearly, GE-wide inter-
action studies (GEWIS) can be even more problematic than
cGE (Thomas, 2010a, 2010b; Thomas, Lewinger, Murcray,
& Gauderman, 2011) because the many tests required in a
GEWIS severely compounds the already low statistical power
to detect an effect. Given the infrequency with which pheno-
types and environments are consistently collected across
studies, it appears infeasible to amass the sample sizes neces-
sary to detect a GE effect at genome-wide significant levels.
GEWIS is not feasible and, for whatever reason, the a
priori selection of candidate genes based on findings in model
organisms (Caspi et al., 2010), for example, is not currently
working. We argue that there are several ways forward.
1. Current atheoretical GWAS approaches can be tweaked to
optimize analysis for identifying GE interactions. These
methods include (a) filtering the set of common SNPs to
retain only those that have promise for interaction, which
we explore in the next section, and (b) combining SNPs
into polygenetic scores, and testing the score for interac-
tion with the environment.
2. GWAS, GE, and psychological theory will benefit from
a developmental perspective.
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3. The standard candidate gene approach has been far from
optimal, but it is due to make a new and improved reap-
pearance. Improved phenotypic and environmental mea-
sures, along with vastly improved genomic knowledge,
can revive candidate gene approaches.
Emerging Approaches to Genetic Interactions
Filtering variants to enrich for interaction
The genomically atheoretical approach of GWAS will not
work for G  E because the testing burden is simply too
heavy. However, we can use our general knowledge about
statistical interactions to devise procedures to filter the vast
number of common SNPs, resulting in a much smaller subset
probabilistically enriched to show interactions (Thomas,
2010a). We briefly discuss three ways to do this. First, filter
out any SNP that does not show a main effect for the pheno-
type. SNPs in the subset of variants with main effects are
known to affect the phenotype in the first place and are
more likely to be differentially relevant depending on the
environment. We can see this in Figure 3. The figure portrays
a series of possible interactions among genotype, environ-
ment, and phenotype. The genotype is a single SNP with al-
leles A and B. On the left-hand side of the figure is a sampling
of the many possible interaction effects. For each interaction
we also give the corresponding main effect that would arise
under that interaction. The main effects are given on the
right-hand side of the figure. Notice that some interactions
imply a main effect (Figure 3a and c), although some do
not (Figure 3b and d). Because we generally have more power
to detect main effects than interaction effects of similar size,
we can use the relationship between main effects and interac-
tions to our advantage. If we restrict tests of interaction only
for those SNPs with demonstrated main effect, for example,
we can greatly reduce the genome-wide testing burden by
rightfully ignoring the massive number of SNPs that lack a
main effect. In addition, we expect the subset of SNPs with
a main effect to be enriched for GE interactions (Marchini,
Donnelly, & Cardon, 2005; Thomas, 2010a).
There are many ways to filter the vast number of SNPs by
main effect. Perhaps the best method is to use variants iden-
tified in the literature, preferably in large meta-samples. How-
ever, using only those variants identified as genome-wide
significant ( p, 51028) may be too restrictive. A more ex-
ploratory GE test might consider, perhaps, the top 100 or
1,000 SNPs with the largest estimated main effects, regard-
less of whether they are significant at p, 51028. The mul-
tiple-testing burden for 100 SNPs is p , .0005, or 51024,
far better than the 51028 incurred for testing all common
SNPs. The actual number of candidate SNPs to include in
such an exploratory study could easily be informed by power
calculations.
Notice that filtering by main effect only works for a subset
of possible interactions, as can also be seen in Figure 3. Only
Figure 3a and c show a main effect in addition to interactions.
Filtering SNPs by main effect will also remove all SNPs that
demonstrate interactions in the absence of main effect
(Figure 3b and d). There are other ways to filter SNPs to en-
rich for interactions in the absence of main effects. For exam-
ple, one might do a test of equality of variances across geno-
types (Pare, Cook, Ridker, & Chasman, 2010). As can be seen
in Figure 3b, for example, one would expect the variances to
differ as a function of genotype. Collapsing across environ-
ment, the variance of the AA allele would be larger than
the BB allele, because of the mean differences due to environ-
ment for the AA and BB genotypes that is not present for the
AB genotype. Every example in Figure 3 would fail a test of
equality of variance (assuming sufficient statistical power)
except for Figure 3d, which is a theoretically possible interac-
tion that shows neither a main effect nor inequality of var-
iance across alleles. Genotypes that fail a test of equality of
variances would be statistically enriched for interactions
and prioritized in subsequent direct tests of GE interaction.
Note, however, that even Figure 3b and d (i.e., “cross-over”
interactions) would demonstrate main effects if genotypes
and environments are unequally balanced.
Combining SNPs into polygenetic SNP scores
Although the individual effect of a SNP is expected to be
small, rendering the expected environmental interaction ef-
fect small, the aggregate effects of SNPs can be quite large.
In the meta-analytic literature on genetic main effects, it has
become common to sum SNPs by their univariate regression
weight, resulting in a single polygenetic score for each indi-
vidual (e.g., see Purcell et al., 2009; Vrieze, McGue, et al.,
2011). The resulting score can have a measureable effect on
the phenotype, even in samples sizes in the thousands, allow-
ing individual investigators to independently test interactions
without the need for combining studies meta-analytically.
Polygenetic scores are not as biologically informative as
individual SNP (or gene) effects, but they can help inform
the genetic and environmental architecture of diseases and
traits. For example, our group has recently conducted work
on a polygenetic GD test for cigarettes smoked per day
(Vrieze, McGue, & Iacono, 2012). The score consisted of a
sum of the top 91 SNPs reported in a recent GWAS meta-
analysis of cigarettes smoked per day in approximately
75,000 smokers (Furberg et al., 2010). In a sample of ap-
proximately 3,000 twins, we found that the SNP score was ir-
relevant at ages 14 and 17, but it was significantly associated
with number of cigarettes smoked per day at ages 20 and 24,
indicating a GD interaction.We speculate that development
here is a proxy for the environmental changes that occur be-
tween ages 17 and 20, and serve to activate genetic influences
on smoking. Most individuals at ages 14 and 17 have diffi-
culty finding the opportunity to smoke more than a handful
of cigarettes per day, if they smoke at all. Smoking is illegal
in the United States at these ages, and the vast majority of
youths are under teacher and/or parent supervision for most
of their waking hours, limiting but by no means eliminating
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their opportunity to smoke. This environmental restriction on
smoking is expected to temper the effect of a risky genotype.
At ages 20 and 24, however, smoking is legal, and young
adults often live and work independently, removing the envi-
ronmental restriction on their genotypic propensity to smoke
more.
Unfortunately, a meta-analytic GWAS of 100,000 indi-
viduals from which to select SNPs with demonstrated main
effects does not exist for every phenotype. Even so, several
options remain. One brute force method is to obtain polyge-
netic scores without meta-analytic guidance, often by sum-
ming across tens of thousands of SNPs (Simonson, Wills,
Keller, & McQueen, 2011). The method often involves ob-
taining the univariate effect of each SNP, culling SNPs in
high LD with more significant SNPs, and then adding the re-
maining SNPs according to their univariate regression
weight. Removing weaker SNPs in high LD with stronger
SNPs removes likely LD-induced artifacts. Depending on
Figure 3. Association between GeneEnvironment interaction (GE) effects and gene main effects. Graphs are organized into rows. The left-
hand graph in each row is an example GE interaction; on the right, is the corresponding main effect (assuming the environmental exposure was
50:50 in this sample). (a) The GE effect, similar to that found in Caspi et al. (2003) also shows a main effect when environment is ignored. The
effect would also show unequal variances across genotypes due to the increasing mean separation between environments as we move from the
AA genotype to the BB genotype. (b) The effect shows an interaction but no main effect, and unequal variances across genotypes are shown. (c)
Although similar to (b), an interaction, a main effect, and unequal variances are shown. (d) This is unique in that the effect shows an interaction
but demonstrates neither a main effect nor unequal variances.
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the LD threshold, this method results in thousands to hun-
dreds of thousands of SNPs comprising the resulting score.
The method has proven useful with the usual anthropometric
traits like height (Allen et al., 2010) and BMI (Speliotes et al.,
2010) and in schizophrenia and bipolar disorder (Purcell
et al., 2009). The score can then be incorporated in tests of
environmental and developmental moderation.
Another viable method to evaluate aggregated SNP inter-
actions is GCTA (Yang, Lee, et al., 2011, described in the
GWAS of Anthropometric Measures, Medical Diseases,
and Behavioral Traits Section). GCTA is a method by which
one can estimate the variance in the phenotype accounted for
bymeasured SNPs. The method uses the estimated genetic re-
latedness between individuals in the sample and models all
SNPs as a random effect in a mixed effects model. Mixed ef-
fects models can include interaction terms between random
and fixed effects (Pinheiro & Bates, 2000), and GCTA has
a built-in facility for evaluating GE interaction, where the
G is the random effect of all measured SNPs and E is the fixed
environmental measurement. At present, the software is re-
stricted to discretely measured environments (e.g., was ex-
posed to disease pathogen, yes/no), but quantitative measures
of the environment are planned for future updates to the algo-
rithm (Jian Yang, personal communication, February 13,
2012). It stands to reason that longitudinal repeated measures
could also be implemented in a GCTA framework, allowing
tests of aggregate SNP effects on developmental trajectories.
There is great promise to extending GCTA to environmental
and developmental interaction, as any study with genome-
wide SNP data becomes immediately genetically informa-
tive, much like a twin study. Twin studies are difficult or
impossible to ascertain for rare phenotype/environment com-
binations, and GCTA could provide a workaround in evaluat-
ing the environmental moderation of genetic effects in these
situations. In the context of a rare natural event (often called a
“natural experiment”; Rutter, 2007), such as a war or a natural
disaster, one could imagine genotyping survivors and com-
paring them to matched controls, conducting a test of GE
using GCTA to determine GE interaction for phenotypes
such as posttraumatic stress disorder. However, this sort of re-
search without using GCTA has been done with hurricane
victims and 5-HTTLPR (Kilpatrick et al., 2007).
Genome-wide polygenetic scores and GCTA have pro-
vided insight about the genetic architecture of disease, but
they otherwise lack direct biological interpretability because
GCTA considers the genome-wide aggregate effect of hun-
dreds of thousands of SNPs simultaneously. Such scores
need not be genome-wide, however, and application of a
scoring approach to a genomic region can provide improved
biological relevance. Using GCTA in a sample of 12,000,
Yang, Manolio, et al. (2011) found that SNPs in genes ex-
plained 38% of the variance in height, whereas SNPs in inter-
genic regions explained only 8%, even though the intergenic
regions made up roughly half of the genome. Taking this
approach one step further, Lee et al. (2012) found that genes
involved in central nervous system function accounted for
approximately 30% of the diagnostic variance in schizophre-
nia, whereas they physically comprise only 20% of the ge-
nome. Other genes also accounted for approximately 30%
of the variance but physically comprise about 40% of the ge-
nome. As sample sizes grow, more refined subsets of genes
can be evaluated. For example, for alcoholism one might in-
vestigate the proportion of variance accounted for by SNPs in
genes known to be involved in alcohol metabolism or candi-
date neurotransmitter systems such as GABA, dopamine, or
serotonin.
Role of GD in evaluating GE
GE studies to date largely have not considered the role of
development. Development can inform genetic studies in at
least two ways. First, it can serve to modify the GE interac-
tion, resulting in a GED interaction. Second, it can serve
as a proxy for the environment in GE. That is, changes in
the environment can correlate strongly with changes in age or
developmental stage, as illustrated in our work on cigarette
smoking where the protective (or, at least, interfering) child-
hood environment becomes less influential as adolescents
age. On a much more basic level, genomic regions have
been linked to embryonic development (Woolfe et al.,
2005). These regions are often involved in regulating protein
transcription from genes involved in development and cell in-
tegrity, are critical in organisms from humans to dogs to fish,
and have been highly conserved across animal species (Lind-
blad-Toh et al., 2005; Pennacchio et al., 2006).
Like cGE studies, candidate GD (cGD) studies in-
volve the selection of a promising genomic region, such as a
gene, and observation of how variants in that region are asso-
ciated with a phenotype at different ages or developmental
stages. An excellent example of a cGD study involves a
SNP in the fat mass and obesity-associated alpha-ketogluta-
rate dependent dioxygenase (FTO) gene known to affect
BMI in adults (Speliotes et al., 2010) by affecting one’s per-
ception of satiation after eating. In a longitudinal meta-anal-
ysis of eight studies, Sovio et al. (2011) demonstrated diver-
gent developmental trajectories for different alleles of SNP
rs9939609. They found that carriers of the at-risk minor allele
of rs9939609 in FTO was significantly associated with a
lower BMI in toddlerhood, an earlier adiposity rebound
around age 5, and higher BMI in early adolescence. The study
demonstrates well the potential complex interplay between
genes and development that can be assessed with relatively
small sample sizes; the Sovio et al. (2011) study had on aver-
age approximately 9,500 participants at any given age of as-
sessment. By the same token, it stresses the need for individ-
ual investigators to share existing data and collaborate on
meta-analytic endeavors.
Our group at the University of Minnesota took the cGD
paradigm in a slightly different direction (Vrieze, McGue
et al., 2011). Our goal was to understand how the Allen
et al. (2010) meta-analytic SNP findings for height play out
developmentally during the pubertal growth spurt. We tested
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for association of 176 of those SNPs with both prepubertal
height and the pubertal growth spurt in a sample of 3,187
twins of Caucasian ancestry from the Minnesota Center for
Twin and Family Research (for a description of the study,
see Miller et al., 2012). No individual SNP was associated
with prepubertal height, or the pubertal growth spurt, at ge-
nome-wide significance. Aggregating the SNPs into a poly-
genetic score (summing them together by their meta-analytic
weights to form a single SNP score) resulted in a much
stronger association with prepubertal height ( p ¼ 110213,
r2 ¼ .045) than with the pubertal growth spurt ( p ¼ .004).
The results indicated that the SNPs identified by the meta-anal-
ysis were more relevant for growth in stature between concep-
tion and 10 years of age,and largely did not explain variation in
the rate at which individuals grew after the onset of puberty.
cG D approaches based on a priori hypotheses about
gene function have also proven useful in some instances.
The Irons et al. (2007) study, involving the gene ALDH2
and described in detail earlier, was expanded in Irons, Iacono,
Oetting, and McGue (2012), where the authors tested the ex-
tent to which the protective effect of ALDH2 changed during
adolescence. Recall that nearly 50% of individuals of East
Asian ancestry inherit a variant in the ALDH2 gene that di-
minishes their ability to metabolize alcohol and that those
who inherit the deficient gene variant are likely to experience
various signs of dysphoria following ingestion of even a small
amount of alcohol. The deficient variant of ALDH2 was
found to be protective against drinking during early adoles-
cence (14–17) and grew increasingly protective as the indi-
viduals aged. The general results are consistent with the
Vrieze et al. (2012) findings for cigarette smoking. That is,
in adolescence the genotype effect existed but was muted,
likely mitigated by protective childhood environmental cir-
cumstances. As the individuals aged, their genotype increas-
ingly exerted influence on their behavior.
The Irons et al. (2012) finding is an excellent example of
GD effects for a psychiatric condition and demonstrates
how a genotype expresses differentially depending on devel-
opmental stage or, perhaps just as likely, environmental con-
text. As the youths develop, their environment systematically
changes, often in ways that can inform knowledge of the in-
terface between genes and environment.
Complementing GWAS: Rare and structural variants
Common SNPs used in GWAS represent a small fraction of
the entirety of genetic individual differences. GWAS disre-
gard entirely rare SNPs and structural variation. Recall the
GCTA findings described above. At best, common SNPs ac-
count for less than half of the total additive genetic variance to
be explained. For the only psychiatric disease to be rigorously
evaluated thus far (schizophrenia), they account for a quarter.
Although nothing to sneeze at, this leaves a large proportion
of the heritability of schizophrenia unexplained by common
SNPs. There are many explanations for the missing heritabil-
ity (Eichler et al., 2010; Zuk, Hechter, Sunyaev, & Lander,
2012), including the existence of GE interactions (Manolio
et al., 2009; Thomas, 2010a), but we focus on one: the fact
that genetic variants in humans are not limited to common
SNPs. Other types of variants are displayed in Figure 1, where
we notice insertions, deletions, substitutions, inversions, vari-
able tandem number repeats, and CNVs. Forms of genetic
variation other than common SNPs are no doubt relevant
for disease, and they are just as likely to be environmentally
and developmentally moderated as common SNPs.
Rare and structural variation is obtained by sequencing,
which has not until recently become technologically or finan-
cially feasible. In current genome sequencing (called “shot-
gun sequencing”), the approach is to obtain several reads
(or measurements) of each base pair. Because each read is rel-
atively error prone, it is desirable to obtain many reads (e.g.,
.30) for each base pair to correctly identify the actual nu-
cleotide. The average number of reads for each base pair is
termed the “depth” of sequencing; the deeper the coverage,
the higher the average number of reads and the more precise
the genotype calls. Ideally, many individuals would be se-
quenced at high depth, which would provide accurate geno-
typing as well as large sample sizes (and power) for tests of
phenotype–genotype associations. However, each read costs
money, and there is thus a trade-off between the number of
individuals sequenced and the depth of sequencing. An opti-
mal trade-off can be selected, but it depends on the research
question (Li, Sidore, Kang, Boehnke, & Abecasis, 2011).
We first provide some context and motivation for whole
genome sequences. The immediate goal of GWAS was to
identify SNP associations with the phenotype. Because sig-
nificant SNPs in a GWAS are unlikely themselves to be func-
tional (i.e., causal) but rather more likely to be in LD with
functional variants, the region around a significant SNP
would be subjected to further genotyping and/or sequencing
to determine how that region, which the SNP has “tagged,” is
causally related to the phenotype. The common SNPs thus
would provide a foothold into biological investigations of
etiology. There have been dramatic examples of this logical
progression from GWAS hits to regional targeted sequencing
and ultimate elucidation of functional variants. We discuss
these to shift our attention from SNPs, which represent very
minor perturbations of the genome, to genes, which are mas-
sive genomic regions integral to human biology and existence.
In a meta-analysis of GWAS on lipids, Teslovich et al.
(2010) found 95 SNPs genome-wide significant for lipid
traits, such as plasma concentrations of cholesterol measures.
As usual, each SNP in the GWAS had only a very small ef-
fect. However, the investigators then developed mouse mod-
els to validate three genes that contained SNPs identified in
the meta-analysis. In the mouse models the investigators
did not simply perturb the GWAS-significant SNPs; rather,
they knocked out or overexpressed the entire gene, with dra-
matic results. The experimental mice showed marked differ-
ences in HDL cholesterol compared to controls. The results
highlight the fact that SNPs identified by GWAS are tag
SNPs, unlikely to be functional themselves, but which can
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point to a gene or larger genomic region that turns out to be
phenotypically critical after further study.
A developmentally relevant example is in human growth.
Widen et al. (2010) conducted a GWAS on growth in height
during puberty. One SNP, located in lin-28 homolog B, was
genome-wide significant for pubertal growth and had pre-
viously been associated with timing of puberty (Ong et al.,
2009) and later further validated by Vrieze, McGue et al.
(2011). Similar to the work on lipids, researchers developed
a mouse model where the mouse gene analog, lin-28 homo-
log A, was overexpressed. The transgenic mice showed dra-
matic change in rate of growth during puberty, change in pu-
bertal initiation, and vastly different adult height and size (Zhu
et al., 2010). Again, GWAS SNPs may only weakly point to a
gene, even though the gene as a whole is crucial to pheno-
typic development.
Genes are the part of the genome that actually encode
amino acids and proteins, and are made up of promoters, en-
hancers, exons, introns, and other gene units. Promoters and
enhancers determine the rate of transcription of a gene: strong
promoters tend to result in higher rates of transcription, and
thus more of the protein(s) encoded by the gene. Weak pro-
moters result in less gene production. The exonic regions of
a gene are those regions that actually encode amino acids
and proteins. Even a single mistake in the exon can com-
pletely change the protein encoded by the gene. In some cases
a nonfunctional protein is produced; in others a chemically
different but functional protein is produced. For example, a
nonsense mutation can break a gene entirely, resulting in a
complete loss of function, similar to that discussed above for
the mouse models. A good example of exomic mutations
with phenotypic impact is in cystic fibrosis, where 1,404 differ-
ent exomicmutations have been catalogued for the cystic fibro-
sis transmembrane conductance regulator gene (http://www.
genet.sickkids.on.ca/cftr/Home.html). Because only a single
functional copy of the cystic fibrosis transmembrane conduc-
tance regulator gene is required for normal function, a child in-
herits cystic fibrosis if both the maternal and the paternal genes
carry at least one nonfunctional mutation. In another, more sen-
sational example, researchers used exome sequencing to make
a novel diagnosis of congenital chloride diarrhea for a patient
who was referred for genetic testing for diagnostic clarification
(Choi et al., 2009). The study demonstrated the potential clin-
ical utility of genome sequences for phenotypically extreme
cases that are not easily diagnostically classified.
Our knowledge of gene structure and function can be le-
veraged in analysis of genotype–phenotype associations. Ma-
jor efforts have been undertaken to characterize variation
within the exome, a term used to describe the collection of
all exonic coding regions contained within the genome. The
1000 Genomes Consortium sequenced the exomes of 697 indi-
viduals at an average depth of 56 (very deep), identifying
12,758SNPswithminorallele frequencygreater than0.1%(Alt-
shuler et al., 2010). Thanks to these efforts, all the functionally
important exomic SNPs can now be genotyped with a relatively
inexpensive exome SNP chip now commercially available.
One problem with exomic association tests is that loss of
function mutations are likely to be very rare, owing to strong
evolutionary selection against these variants. Because power
is extremely low for rare variants (de Bakker et al., 2005), dif-
ferent analytic strategies are devised and used to handle them
(Bansal et al., 2010). One attractive method is to determine
the functionality of each SNP within some region, such as a
gene, and then predict the extent to which that region is im-
paired (Cooper & Shendure, 2011; Torkamani, Scott-Van
Zeeland, Topol, & Schork, 2011). For example, if an individ-
ual carries even one nonsense exonic mutation within a gene,
then the gene for that person would be predicted to be non-
functional. This is precisely the etiology of cystic fibrosis,
where there are many potential nonsense exonic mutations
(among other types of mutations), all of which lead to the
same phenotype. Regardless of the phenotype, one can test,
for example, whether cases versus controls are more likely
to have nonfunctional genes. Regression analysis can be
used for quantitative traits, regressing the phenotype onto pre-
dicted functionality for each gene. ENCODE and other
extensive databases are continuously updated with reams of
genomic information. For instance, dbSNP catalogues all
identified SNPs in any organism and their population charac-
teristics (e.g., minor allele frequency, chromosomal position);
OMIM catalogues known disease-causing mutations; and the
ENCODE consortium is an attempt to discover, define, and
list the functional elements of the human genome (Myers
et al., 2011). Software has been developed to automatically
leverage the immensity of information in these databases
and apply it to individual genotypes in our studies. A list of
such software is given in Cooper and Shendure (2011).
Although not yet widely applied to psychiatric pheno-
types, exome sequencing has shown promise in identifying
genes relevant to phenotypes ranging from autism (O’Roak
et al., 2011) and schizophrenia (Xu et al., 2011) to mental re-
tardation (Vissers et al., 2010). As exome sequencing be-
comes more affordable and the exome SNP chip more com-
monly used, we expect exomic studies of psychiatric
disease and psychological traits to become increasingly com-
mon.
Structural variation is a substantial source of genetic dif-
ferences between individuals. Structural variants include
CNVs, indels, substitutions, and inversions, all of which
are displayed in Figure 1. The extent of this variation is im-
mense and has only recently been well characterized, thanks
to the 1000 Genomes Consortium and related projects. Alt-
shuler et al. (2010) identified that individuals on average
have 361,669 indels, 96 of which occur in exonic regions.
(Recall that one deleterious variant within an exon can disrupt
a gene entirely, so it is not trivial that individuals on average
have 96 exonic insertions or deletions.) The same study found
that individuals on average have 10,000–11,000 nonsynon-
ymous SNPs and around 570 in-frame structural variants
(not counting CNVs) that likely have greater functional im-
pact than single SNPs. “Nonsynonomous” means the SNP
disrupts the protein-coding sequence, whereas an “in-frame”
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variant simply means that the variant significantly overlaps
with the parts of the gene that code a protein. Of these, ap-
proximately 370 of the variants are likely to result in loss of
function in the gene, rather than gain of function. In total
these loss of function variants affect approximately 275 genes
per individual in the study. In a follow-up study of CNVs,
Mills et al. (2011) identified 28,025 CNVs, 10,995 of which
overlap with genes, in many cases including the exon (1,119).
Structural variants represent a significant source of genetic
variation, much of which theoretically has substantial import
for the genetic etiology of disease (Stankiewicz & Lupski,
2010).
Psychiatric genetics and behavior genetics have begun to
evaluate CNVs in disease, with some notable results for
schizophrenia (Levinson et al., 2011), bipolar disorder
(Priebe et al., 2011), and autism (Cook & Scherer, 2008).
Promising results have also been found for neurodevelop-
mental conditions such as attention-deficit/hyperactivity dis-
order (Elia et al., 2010, 2012). Other forms of structural
variation, including shorter CNVs, can now feasibly be mea-
sured with sequencing pipelines and reference genotypes pro-
vided by the 1000 Genomes Consortium (Mills et al., 2011).
As more main effects of structural variants are discovered,
they must be leveraged along with rare and common SNPs
to assist in elucidation of genetic, environmental, and devel-
opmental etiology of disease. All of the techniques discussed
above for SNPs (except perhaps GCTA) are applicable to
structural variation, and we expect research in this area to
begin blossoming in the near future as sequencing becomes
routine.
The return of the Candidate Gene Study
In theworld after the HumanGenome Project, psychiatric and
behavior genetics has swung from a field dominated by the
candidate gene approach, and its a priori hypotheses, to one
relying on the brute force of atheoretical GWAS. With the ad-
vent of affordable whole genome sequencing and functional
annotation, we expect the pendulum to begin swinging
back. Science has and will benefit from data-driven ap-
proaches like GWAS, but scientific psychology requires the-
ory to integrate findings and focus our experimental tests
(Caspi et al., 2010). A major stumbling block of the candidate
gene and cGE approach has been the lack of theory and un-
derstanding about genomics and genetic etiology; unknown
at the time, the candidates were not so good and expected ef-
fect sizes were highly optimistic. GWAS, although not curing
diseases, has been an exciting learning exercise. To exagger-
ate for effect, we now know that testing some genetic theory
of behavior using small samples, genetically uninformed
phenotypes, poorly measured environments, no consideration
of developmental circumstance, and a handful of SNPs in a
single gene will not do the trick. GWAS undoubtedly will
continue to provide leads (Visscher et al., 2012) and point
the way to relevant genes. Encouraged by past success, ever
more investigators are sharing data to arrive at the required
massive sample sizes. Consortia are even popping up with de-
velopmental and environmental questions: our group is con-
tributing to a consortium evaluating adolescent cigarette
smoking, for example. Identified SNPs will point to genomic
regions that will be subjected to further study. Transgenic
mice will be created. Identified genes will be sequenced, var-
iants annotated and grouped, and tested in new samples.
GWAS will only get us so far. Etiological psychological
theories must be proposed, tested, and amended. Although
biological reductionism is perhaps not always preferable or
possible (Miller, 2010), theories would do well to propose,
derive, and test increasingly refined endophenotypes. Multi-
disciplinary biological, neuroscientific, and psychological re-
search will point to chemical and structural systems relevant
to psychological endophenotypes, such as neurochemical
systems. Gene(s) known to be involved in those systems, if
not the whole genome, will be cheaply sequenced. Lever-
aging knowledge of gene function, the entirety of genetic var-
iation within the gene(s) can be tested for association with the
endophenotype. At the same time, psychological research on
environmental etiology and measurement will continue, iden-
tifying environments likely to have causal phenotypic effects.
Tests of GE and GD can commence once plausible can-
didate genes have been identified.
This brief outline of candidate gene research is not pre-
scriptive; the steps by no means must proceed in that order.
Rather, it is an attempt to describe what we see as important
waypoints in the path to understanding genetic and environ-
mental etiology of behavior. In some fields many of the steps
have already been taken. There is a wealth of neuroscience
and biological findings for alcoholism, for example, with ex-
cellent animal models providing a wealth of biological
knowledge (Spear, 2000), including metabolic and neuro-
transmitter systems implicated in alcohol use and abuse
(Hodgkinson et al., 2008); plausible etiological theories in
psychology (Iacono et al., 2008); and well-validated endo-
phenotypes (Iacono & Malone, 2011). The environmental
etiology is continuously elucidated (Irons et al., 2007; Keyes
et al., 2008), and several studies are already obtaining whole
genome sequences on human samples informative for alcohol
and drug use, abuse, and addiction.
Summary
Simply getting off the ground and identifying robust and
replicable genetic effects has been difficult. Nonetheless, the
field as a whole has learned a lot about genes, environments,
and behaviors in the process. Twin, adoption, and family
studies formed the foundation and continue to be indispensi-
ble in forming and refining psychological theory. With mea-
sured genetic variation, this research can be taken to a more
biologically and environmentally informative level, as behav-
iorally relevant genetic variants are discovered and their ef-
fects characterized. Although common SNPs may account for
a significant proportion of heritability, there remains a very
substantial source of genetic structural variation that is only
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beginning to be tapped. Environmental and phenotypic defi-
nitions and measurements are likely far from optimal. Better
measurements, including endophenotypes, help everyone, psy-
chologist and geneticist alike, and will only improve the sci-
ence and simultaneously increase the power for genetic asso-
ciations. Current directions in quantitative psychiatric disease
definition inDSM-V (Krueger et al., 2011), efforts at standard-
ized environmental measures like the PhenX Toolkit, ever-
cheaper sequencing, and improved knowledge of genomic
structure and function will provide investigators with powerful
tools to disentangle genomic, environmental, and develop-
mental etiology in psychological behavior and disease. The
coming decade will be an exciting one for psychologists inter-
ested in understanding the causes of human behavior.
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